
Corgi Genomics & Precision Medicine ETF (GNMX) Price & Holdings
GNMXBATSCorgiEquity
As of Nov 20, 2026 close
- Assets (AUM)
- $2.80M
- Expense ratio
- 0.35%
- Dividend yield
- -
- Holdings
- 59
- 52-week range
- $23.88$39.86
- Volume (live)
- -
- Avg. volume (3M)
- 1.21K
GNMX ETF Price Chart
Loading chart...
GNMX Key Statistics & Financial Metrics
Fund characteristics, expense ratio, dividend yield, and performance metrics
| Day's Range | $32.06 - $33.02 |
|---|---|
| 52-Week High | $39.86 |
| 52-Week Low | $23.88 |
| Open | $33.02 |
| Volume (last close) | 3.03K |
| Average Volume (3M) | 1.21K |
| 1 Day Change | −1.17% |
|---|---|
| 1 Month Change | −12.84% |
| 6 Month Change | +30.89% |
| YTD Change | +28.63% |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Assets (AUM) | $2.80M |
|---|---|
| Expense Ratio | 0.35% |
| Total Holdings | 59 |
| Inception Date | May 5, 2026 |
| 50-Day MA | $36.67 |
|---|---|
| RSI | 36.22 |
| Stochastic %K | 0.00 |
| Stochastic %D | 1.58 |
Source: Exchange price data and fund disclosures. Data as of Nov 20, 2026. Data sources and methodology
GNMX at a Glance
Corgi Genomics & Precision Medicine ETF (GNMX) is an equity ETF from Corgi, launched in May 2026. It manages $2.80M in assets and charges a 0.35% expense ratio, about $35 a year per $10,000 invested.
Based on holdings data updated Oct 4, 2026, it holds 59 positions. The largest are Thermo Fisher Scientific Inc (TMO, 8.45%), Moderna, Inc. (MRNA, 8.40%) and Vertex Pharmaceuticals Incorporated (VRTX, 6.52%). The top 10 holdings make up 48.4% of the fund. By sector it leans toward Healthcare (100.0%). 92.6% of assets are in the United States.
It does not currently pay distributions.
Frequently Asked Questions About Corgi Genomics & Precision Medicine ETF
What is the current price of GNMX?
The latest GNMX price is $32.06 (Nov 20, 2026 close). The 52-week range is $23.88–$39.86.
What is the expense ratio for GNMX?
GNMX's annual expense ratio is 0.35%, about $35 a year for every $10,000 invested.
Does GNMX pay dividends?
Corgi Genomics & Precision Medicine ETF has paid no distributions in the trailing 12 months to the Nov 20, 2026 close. FinSpry has no recorded distribution history for the fund.
What are the top holdings of GNMX?
In holdings data last updated Oct 4, 2026, GNMX's largest holdings are Thermo Fisher Scientific Inc (8.4%), Moderna, Inc. (8.4%), Vertex Pharmaceuticals Incorporated (6.5%) (combined weight: 23.4%). The fund holds 59 total positions. View the complete portfolio breakdown in the Holdings section.
How concentrated is GNMX's portfolio?
In holdings data updated Oct 4, 2026, the top 10 holdings make up 48.4% of GNMX's assets across 59 positions. Its largest sector weight is Healthcare at 100.0%.
How large is GNMX and when did it launch?
GNMX manages $2.80M in assets. Corgi launched the fund on May 5, 2026, less than a year before the Nov 20, 2026 close.